BiotechTube
Home/Hematologics/Michael R. Loken
MR

Michael R. Loken

PhD, Scientific Founder/Leader

Hematologics

Therapeutic Areas

Hematologic MalignanciesAcute LeukemiaMyelodysplastic SyndromesMultiple Myeloma

Hematologics Pipeline

DrugIndicationPhase
MRD Testing ServiceAcute LeukemiasCommercial
Cytopenias/MDS Diagnostic ServiceMyelodysplastic Syndromes & CytopeniasCommercial
Plasma Cell Neoplasm ServiceMultiple Myeloma & Plasma Cell DisordersCommercial
Biopharmaceutical Clinical Trial ServicesHematologic Malignancies (Clinical Trial Support)Commercial
Integrated HLA LOH Assay (with Versiti)Informs Immunotherapy DecisionsCommercial

Leadership Team at Hematologics

DA
Denise A. Wells
MD, Clinical Pathologist
DX
Dongbin Xu
PhD, FACMG, Molecular Genetics/Cytogenetics
CH
Chad Hudson
MD
BS
Ben Stueben
MD
View full Hematologics profile